Ramiro Jover
Impact in
- Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Hepatology top 1%
- Liver physiology and pathology
Papers in
- Pharmacology 47
- Pharmacogenetics and Drug Metabolism 36
- Drug-Induced Hepatotoxicity and Protection 20
- Hepatology 22
- Liver physiology and pathology 13
- Co-authors
- José V. CastellM. José Gómez‐LechónM. Teresa DonatoM.J. Gómez-LechónXavier PonsodaRoque BortJavier González‐GallegoSonia Sánchez‐Campos
- Journals
- Toxicology in Vitro (10 papers)Journal of Hepatology (6 papers)Current Drug Metabolism (6 papers)Molecular Pharmacology (5 papers)Alternatives to Laboratory Animals (5 papers)
- Partner nations
- SpainNetherlandsGermany
In The Last Decade
Ramiro Jover
115 papers receiving 5.3k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Pharmacology 1.8k
- Hepatology 796
- Biochemistry 363
- Oncology 1.2k
- Epidemiology 1.1k
Countries citing papers authored by Ramiro Jover
This map shows the geographic impact of Ramiro Jover's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramiro Jover with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramiro Jover more than expected).
Fields of papers citing papers by Ramiro Jover
This network shows the impact of papers produced by Ramiro Jover. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramiro Jover. The network helps show where Ramiro Jover may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ramiro Jover, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 11 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 9 | |
| 7 | 2022 | 1 | |
| 8 | 2021 | 91 | |
| 9 | 2016 | 21 | |
| 10 | 2016 | 59 | |
| 11 | 2011 | 5 | |
| 12 | 2010 | 25 | |
| 13 | 2009 | 69 | |
| 14 | Desarrollo, análisis y optimización de modelos celulares hepáticos para estudios de fármaco-toxicología y terapia celular | 2008 | 4 |
| 15 | 2004 | 202 | |
| 16 | 2003 | 37 | |
| 17 | 2001 | 178 | |
| 18 | 2000 | 87 | |
| 19 | 1995 | 34 | |
| 20 | 1991 | 28 |
About Ramiro Jover
Ramiro Jover is a scholar working on Pharmacology, Hepatology, Oncology, Epidemiology and Biochemistry, having authored 116 papers that have together received 5.4k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (36 papers), Liver Disease Diagnosis and Treatment (34 papers), Drug Transport and Resistance Mechanisms (27 papers), Drug-Induced Hepatotoxicity and Protection (20 papers), Pancreatic function and diabetes (14 papers), Liver physiology and pathology (13 papers), Diet and metabolism studies (10 papers) and Computational Drug Discovery Methods (8 papers). The work is most often cited by research in Pharmacology (1.8k citations), Hepatology (796 citations), Biochemistry (363 citations), Oncology (1.2k citations) and Epidemiology (1.1k citations). Ramiro Jover has collaborated with scholars based in Spain, Netherlands and Germany. Frequent co-authors include José V. Castell, M. José Gómez‐Lechón, M. Teresa Donato, M.J. Gómez-Lechón, Xavier Ponsoda, Roque Bort, Javier González‐Gallego, Sonia Sánchez‐Campos, María Victoria García‐Mediavilla and Marta Benet. Their work appears in journals such as Toxicology in Vitro, Journal of Hepatology, Current Drug Metabolism, Molecular Pharmacology and Alternatives to Laboratory Animals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.